Skip to content

Home/Archive/PubMed

PubMed · 16906668

FDA approval: darunavir.

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Darunavir Drug Approval HIV Infections HIV Protease Inhibitors Sulfonamides United States United States Food and Drug Administration Newspaper Article Journal Article

Keep this discovery

Explore connections, maps & timelines

Paul E Sax. 2006. FDA approval: darunavir.. https://pubmed.ncbi.nlm.nih.gov/16906668/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

TMC114 approved for resistant patients.

Explore the source record for details and available documents.

Darunavir↗

PubMed2006

FDA clears HIV drug for patients with resistant virus.

Explore the source record for details and available documents.

Darunavir↗

PubMedDate not supplied

Prezista (darunavir, TMC-114) approved; may be important treatment advance.

A major new antiretroviral has been approved, for patients resistant to more than one protease inhibitor. There is no information yet on risk/benefit compared to standard treatments for first-line use. Tibotec, which developed the drug and is now part of Johnson & Johnson, showed price restraint and avoided setting a new record high price, which other companies have done.

Darunavir↗